PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084778
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084778
Materiovigilance Market is estimated to be valued at USD 97.4 Bn in 2026 and is expected to reach USD 167.0 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 97.4 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 167.0 Bn |
Materiovigilance, also known as medical device vigilance, is the collection, assessment, reporting and identification of trends in incidents resulting from the use of medical devices. Medical device vigilance aims to protect the patients, healthcare facilities utilizing medical devices, and others by preventing or reducing the occurrence of errors that leads to harmful incidents and adverse effects. The detection of technical issues and potential adverse effects associated with medical devices is monitored by materiovigilance. Materiovigilance includes postmarket surveillance, adverse reactions, incidents and recalls of medical devices. Adverse reactions can occur due to use of medical devices and can have severe consequences.
Factors such as increasing launches of security plans for medical devices and increasing number of medical device platforms are expected to drive the growth of the global materiovigilance market over the forecast period. For instance, in July 2017, Medical Device Innovation, Safety and Security Consortium (MDISS), a non-profit professional organization with a focus on the safety and security of medical devices, launched a new security testing lab called the World Health Information Security Testing Lab (WHISTL) for medical devices. WHISTL focuses on management and improvement of medical device security and education. For instance, according to data published by Meditology Services, is an IT company that provides security and privacy risk assessment solutions, in August 2021, the U.S. Food and Drug Administration announced a plan to improve cybersecurity practices for medical devices in response to the White House's effort to bolster cybersecurity across the supply chain.